• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.14% Nasdaq Down 0.35%

    Alimera Sciences, Inc. (ALIM)

    -NasdaqGM
    3.01 Down 0.16(5.05%) Sep 3, 4:00PM EDT
    Add to Portfolio
    Prev Close:3.17
    Open:3.17
    Bid:2.57 x 100
    Ask:4.20 x 1500
    1y Target Est:11.00
    Beta:1.49987
    Earnings Date:Nov 4 - Nov 9 (Est.)
    Day's Range:3.00 - 3.20
    52wk Range:2.73 - 6.48
    Volume:79,802
    Avg Vol (3m):96,665
    Market Cap:133.68M
    P/E (ttm):N/A
    EPS (ttm):-0.81
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALIM

    Comparison

    Symbol% ChgMkt Cap
    ALIMDown 5.05%133.68M
    AGNDown 0.72%117.08B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):10.16
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.79
    Quarterly EPS Est (Sep-15) :-0.20
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback